Mylan hit with racketeering suit over big price hikes of EpiPen

Mylan hit with racketeering suit over big price hikes of EpiPen

“Mylan has spent the past year blaming Washington, the prescription drug supply chain, and competitors for its unusual pricing practices. It’s time for them to look in the mirror and take responsibility for their own actions.”